JFMC33-0502_2A: JFMC33-0502, figure 2A

JFMC33-0502_2AR Documentation

JFMC33-0502, figure 2A

Description

Kaplan-Meier digitized data from JFMC33-0502, figure 2A (PMID 26347106). A reported sample size of 1,071 for a primary endpoint of DFS in colorectal cancer.

Usage

`JFMC33-0502_2A`

Format

A data frame of 1,060 observations and 3 variables:

time event time (in years)
event DFS event indicator (0: no event, 1: event)
arm treatment arms (control, study)

Source

Sadahiro S, Tsuchiya T, Sasaki K, et al. Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502. Ann Oncol 2015; 26: 2274–80.

Examples

summary(`JFMC33-0502_2A`)

kmplot(`JFMC33-0502_2A`)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.